ILIBRIFT
5MG TBL FLM 112
| SÚKL code | 0223468 |
|---|---|
| Name of the product | ILIBRIFT |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ILIBRIFT |
| Supplement | 5MG TBL FLM 112 |
| Strenght | 5MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 112 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | IVABRADINE HYDROCHLORIDE (IVABRADINI HYDROCHLORIDUM) |
| ATC group | C01EB17 |
| ATC group name | IVABRADIN |
Marketing authorisation information
| Registration Number | 41/ 830/15-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 10. 2021 |
| MA Holder | Zentiva, k.s., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Auxilto Healthcare s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz